BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 10628322)

  • 41. Accumulation of p53 in esophageal squamous cell carcinoma.
    Chino O; Kijima H; Shimada H; Nishi T; Tanaka H; Kise Y; Kenmochi T; Himeno S; Machimura T; Tanaka M; Inokuchi S; Tajima T; Osamura RY; Makuuchi H
    Int J Mol Med; 2001 Oct; 8(4):359-63. PubMed ID: 11562772
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Sputum cytologic atypia predicts incident lung cancer: defining latency and histologic specificity.
    Byers T; Wolf HJ; Franklin WA; Braudrick S; Merrick DT; Shroyer KR; Hirsch FR; Zeng C; Barón AE; Bunn PA; Miller YE; Kennedy TC
    Cancer Epidemiol Biomarkers Prev; 2008 Jan; 17(1):158-62. PubMed ID: 18199720
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The p53 codon 72 polymorphism and lung cancer risk.
    Fan R; Wu MT; Miller D; Wain JC; Kelsey KT; Wiencke JK; Christiani DC
    Cancer Epidemiol Biomarkers Prev; 2000 Oct; 9(10):1037-42. PubMed ID: 11045785
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Mutated p53 as a molecular marker for the diagnosis of head and neck cancer.
    van Houten VM; Tabor MP; van den Brekel MW; Kummer JA; Denkers F; Dijkstra J; Leemans R; van der Waal I; Snow GB; Brakenhoff RH
    J Pathol; 2002 Dec; 198(4):476-86. PubMed ID: 12434417
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Telomerase activity and Bcl-2 expression in non-small cell lung cancer.
    Ohmura Y; Aoe M; Andou A; Shimizu N
    Clin Cancer Res; 2000 Aug; 6(8):2980-7. PubMed ID: 10955774
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Molecular alterations and lung tumors in p53 mutant mice exposed to cigarette smoke.
    De Flora S; Balansky RM; D'Agostini F; Izzotti A; Camoirano A; Bennicelli C; Zhang Z; Wang Y; Lubet RA; You M
    Cancer Res; 2003 Feb; 63(4):793-800. PubMed ID: 12591728
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Expression of p53 protein and the apoptotic regulatory molecules Bcl-2, Bcl-XL, and Bax in locally advanced squamous cell carcinoma of the lung.
    Shabnam MS; Srinivasan R; Wali A; Majumdar S; Joshi K; Behera D
    Lung Cancer; 2004 Aug; 45(2):181-8. PubMed ID: 15246189
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [The role of p53 tumor suppressor gene as prognostic factor in laryngeal squamous cell carcinoma].
    Garozzo A; Cutrona D; Palmeri S; Maiolino L; Puzzo L; Allegra E
    Acta Otorhinolaryngol Ital; 1999 Dec; 19(6):342-7. PubMed ID: 10875157
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The relationship of p53 immunostaining to survival in carcinoma of the lung.
    McLaren R; Kuzu I; Dunnill M; Harris A; Lane D; Gatter KC
    Br J Cancer; 1992 Oct; 66(4):735-8. PubMed ID: 1329907
    [TBL] [Abstract][Full Text] [Related]  

  • 50. K-ras mutations in lung carcinomas from nonsmoking women exposed to unvented coal smoke in China.
    Keohavong P; Lan Q; Gao WM; DeMarini DM; Mass MJ; Li XM; Roop BC; Weissfeld J; Tian D; Mumford JL
    Lung Cancer; 2003 Jul; 41(1):21-7. PubMed ID: 12826308
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Sputum cells from lung tumor patients carry a cell surface marker not found in normal sputum.
    Steven FS; Payne PW; Palcic B; Lee A; Katsumi TA
    Anticancer Res; 1998; 18(4B):2855-8. PubMed ID: 9713474
    [TBL] [Abstract][Full Text] [Related]  

  • 52. p53 immunostaining in combined type small cell lung cancer. Brief report.
    Higashiyama M; Doi O; Yokouchi H; Kodama K; Tateishi R
    APMIS; 1995 Jun; 103(6):477-80. PubMed ID: 7546652
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Detection of sputum cofilin-1 as indicator of malignancy.
    Rangel MP; Antonangelo L; Acencio MMP; Faria CS; de Sá VK; Leão PS; Farhat C; Fabro AT; Longatto Filho A; Reis RM; Takagaki T; Capelozzi VL
    Braz J Med Biol Res; 2018; 51(8):e7138. PubMed ID: 29846436
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Tissue hyaluronan expression, as reflected in the sputum of lung cancer patients, is an indicator of malignancy.
    Rangel MP; de Sá VK; Martins V; Martins JR; Parra ER; Mendes A; Andrade PC; Reis RM; Longatto-Filho A; Oliveira CZ; Takagaki T; Carraro DM; Nader HB; Capelozzi VL
    Braz J Med Biol Res; 2015 Jun; 48(6):557-67. PubMed ID: 25992645
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Detection of p53 protein in induced sputum after occupational exposure to crystalline silica.
    Shaham J; Fireman E; Korenstein-Ilan A; Lerman Y
    J Occup Environ Med; 2007 Jul; 49(7):730-5. PubMed ID: 17622845
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Carcinogenicity in mice of soot extract collected from Xuan Wei County].
    Liang CK; Guan NY; Ma F; Zhang Y; Wang EM; Yin XR
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1983 Oct; 5(5):307-10. PubMed ID: 6329534
    [No Abstract]   [Full Text] [Related]  

  • 57. Plant cells mimicking adenocarcinoma in sputum.
    Hirokawa M; Shimizu M; Kanahara T; Manabe T
    Acta Cytol; 1998; 42(5):1306-7. PubMed ID: 9755687
    [No Abstract]   [Full Text] [Related]  

  • 58. Vacuolated cells in the sputum simulating adenocarcinoma cells.
    PHILPS FR
    Br J Cancer; 1956 Mar; 10(1):24-5. PubMed ID: 13342316
    [No Abstract]   [Full Text] [Related]  

  • 59. Adenocarcinoma cells in the sputum.
    PHILPS FR
    Br J Cancer; 1954 Sep; 8(3):420-1. PubMed ID: 13230373
    [No Abstract]   [Full Text] [Related]  

  • 60. [Tumor cells in sputum].
    NORDEN JG
    Nord Med; 1948 Oct; 40(43):1951-3. PubMed ID: 18207981
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.